Lansing Street Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Sell
3,835
-46
-1% -$15.7K 0.29% 61
2026
Q1
$1.37M Sell
3,881
-51
-1% -$18.2K 0.34% 54
2025
Q4
$1.29M Sell
3,932
-5
-0.1% -$1.59K 0.33% 56
2025
Q3
$1.11M Buy
3,937
+54
+1% +$15.7K 0.29% 64
2025
Q2
$1.08M Sell
3,883
-55
-1% -$15.6K 0.32% 59
2025
Q1
$1.23M Buy
3,938
+1,371
+53% +$405K 0.41% 41
2024
Q4
$669K Sell
2,567
-15
-0.6% -$4.45K 0.23% 56
2024
Q3
$832K Buy
2,582
+32
+1% +$10.5K 0.31% 50
2024
Q2
$797K Buy
2,550
+45
+2% +$13.2K 0.33% 50
2024
Q1
$712K Buy
2,505
+764
+44% +$224K 0.32% 54
2023
Q4
$502K Buy
+1,741
New +$474K 0.26% 57
2023
Q2
$381K Sell
1,714
-1,588
-48% -$368K 0.22% 59
2023
Q1
$798K Buy
3,302
+153
+5% +$37.6K 0.5% 40
2022
Q4
$827K Buy
3,149
+742
+31% +$199K 0.57% 41
2022
Q3
$543K Buy
2,407
+619
+35% +$150K 0.42% 47
2022
Q2
$435K Sell
1,788
-6
-0.3% -$1.47K 0.34% 48
2022
Q1
$452K Buy
+1,794
New +$412K 0.29% 51

Other funds holding AMGN

Lansing Street Advisors's AMGN Position: Q2 2026 in Review

Lansing Street Advisors reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $15.7K and leaving 3,835 shares worth $1.39M. The position accounts for 0.29% of the portfolio, ranked #61.

Lansing Street Advisors first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lansing Street Advisors held 3,835 shares of Amgen worth $1.39M as of Q2 2026.
  • Lansing Street Advisors sold 46 Amgen shares in Q2 2026, an estimated $15.7K.
  • Amgen made up 0.29% of Lansing Street Advisors's portfolio in Q2 2026, its #61 holding.
  • Lansing Street Advisors first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lansing Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.